$32.48
00.00%
Pre-Market: 4:00 PM EDT
Harmony Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harmony Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $1.03 | $0.66 | 56.1 % |
Jun 2024 | 2024-08-06 | $1.05 | $-0.06 | 1850.0 % |
Mar 2024 | 2024-04-30 | $0.88 | $0.62 | 41.9 % |
Dec 2023 | 2024-02-22 | $0.73 | $0.48 | 52.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $186.04M | $184.06M | 1.07 % |
Jun 2024 | 2024-08-06 | $172.81M | $172.53M | 0.16 % |
Mar 2024 | 2024-04-30 | $154.62M | $154.80M | -0.12 % |
Dec 2023 | 2024-02-22 | $168.41M | $169.06M | -0.38 % |
Harmony Biosciences (HRMY) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $1.03, which beat the estimate of $0.66.
The Actual Revenue was $186M, which beat the estimate of $184.1M.
Browse earnings estimates, EPS, and revenue on all stocks.